Impact of serum AMH level on treatment of PCOS patients with Clomiphene citrate
Not Applicable
- Conditions
- Health Condition 1: R688- Other general symptoms and signs
- Registration Number
- CTRI/2022/04/041956
- Lead Sponsor
- PGIMER
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
PCOS PATIENTS VISITING THE INFERTILITY CLINIC FOR MANAGEMENT OF INFERTILITY
Exclusion Criteria
HYPOTHYROIDSM,HYPERPROLACTINEMIA,DIABETES,H/O ESTABLISHED ENDOMETRIOSIS,H/O PELVIC TUBERCULOSIS,PATIENTS UNWILLING TO PARTICIPATE IN THE STUDY
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method MBER OF PRE OVULATORY FOLLICLESTimepoint: DAY 15 AND DAY 18 OF MENSTRUAL CYCLE OF THE PATIENT IN WHICH SHE RECEIVES TREATMENT WITH CLOMIPHENE CITRATE
- Secondary Outcome Measures
Name Time Method clinical pregnancy rate,ongoing pregnancy rate,biochemical pregnancy rate,miscarriage rateTimepoint: 6weeks